About This Article
To evaluate the safety of efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), and its effects on body weight management in adults without diabetes.
![Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study thumbnail](https://prosciento.com/wp-content/uploads/2022/01/journal-10.png)
To evaluate the safety of efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), and its effects on body weight management in adults without diabetes.